OCTOBER 18, 2022
Global biopharmaceutical services leader, Allucent, today announced that it is continuing to grow its presence and cultivate its talent and capabilities in India with the opening of its second office in the country. The new 15,675 square-foot office, located in Chennai, will add approximately 35 jobs to start, and is part of the company’s strategic plan for continued growth in India over the next several years.
“The impressive talent available in India is well-suited to our operational and support functions across Allucent, and brings tremendous value to our sponsors’ programs,” said Sivakumar Subramanian, head of the Chennai office, Allucent. “Chennai provides the right infrastructure and the right skill sets to meet our partners’ needs. We’re thrilled to be opening our office here, which along with our existing Bangalore office, deepens our capabilities and offers employees an enhanced sense of community and professional purpose. We look forward to continued growth in India in the years to come.”
With a focus on supporting clients globally, the new Chennai office will execute services related to data management, statistical programming, biostatistics, and eTMF (electronic Trial Master File). It will also provide support functions across human resources, facilities and administration, finance, and IT.
“The geographic diversity and reach of Allucent fosters a culture of innovation and creative, efficient problem-solving that benefits our partners, investigator sites, and patients alike,” said Christopher Brennan, chief operating officer, Allucent. “Cultivating talent and capabilities in India is an integral part of this mix, and we’re committed to growing our presence here as we continue to enhance our first-in-class services for clients across the globe.”